ntibodies play an essential role in medicine.
Today diagnosis and treatment of many diseases require these "magic bullets". Furthermore, antibodies are essential components of a myriad of biomedical research. Hence, producing high quality premium antibodies is a great concern in molecular medicine and biotechnology. Since antibodies are produced in complex matrices i.e. serum for polyclonal antibody and cell culture media for monoclonal antibody, efficient purification of antibodies becomes imperative.
Affinity purification is among the most extensively used methods for antibody purification. Affinity purification offers high selectivity and purity levels often above 95% in one step (1) . Due to high specificity, antigen-specific affinity purification is the most popular method for affinity purification Blocking
Step in Affinity Purification Therefore, when the blocking step is not carried out, the purification process is error-prone: since it is common for the researchers to measure the protein levels of fractions and select the fractions with high protein levels, the correct purified antibody fractions would be missed and the wrong fractions would be saved for future assays rendering subsequent studies less efficient.To the best of our knowledge, there are no data about a "blocking" step in affinity purification of antibodies in the literature.
